Hospital
ST Luke's Magic Valley Regional Medical Center LTD
ST Luke's Magic Valley Regional Medical Center LTD was paid $577K by Medicaid between Jan 2018 and Oct 2024, across 51 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 68% of everything it billed.
33Billing provider infoST LUKE'S MAGIC VALLEY REGIONAL MEDICAL CENTER LTD
JEROME, ID 83338
JEROME, ID 83338
33aNPI1366874877assigned 08/07/2013
33bProvider typeCritical Access Hospital
28Total paid$577K
24GClaims24,337
24DCodes billed51
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Critical Access Hospital providers in Idaho
Rank by total paid#8 of 20
Median peer was paid$348K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FOWLER, KATHRYN controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,739 | $170K | |
| 2019 | 9,858 | $288K | |
| 2020 | 5,142 | $112K | |
| 2021 | 51 | $24.03 | |
| 2022 | 659 | $2K | |
| 2023 | 656 | $4K | |
| 2024incomplete | 232 | $967.19 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 68% | 169 | 165 | $394K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.2% | 3,796 | 3,399 | $24K |
| 80053 | Comprehensive metabolic panel | 4.1% | 2,874 | 2,640 | $24K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 955 | 930 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 508 | 496 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 117 | 112 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 233 | 225 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 233 | 225 | $8K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 660 | 636 | $8K |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 3,944 | 3,455 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 751 | 723 | $5K |
| 87430 | <1% | 358 | 353 | $5K |
39 more codes
| 83690 | <1% | 735 | $5K | |
| 81001 | <1% | 1,428 | $5K | |
| 87081 | <1% | 627 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 567 | $4K |
| 99283 | Emergency room visit (moderate) | <1% | 28 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 658 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 433 | $4K |
| 80061 | Lipid panel | <1% | 361 | $3K |
| 86140 | <1% | 557 | $3K | |
| 87077 | <1% | 320 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 711 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 25 | $2K |
| 99284 | Emergency room visit (serious) | <1% | 17 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 494 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $2K |
| 83605 | <1% | 159 | $1K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 405 | $1K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 14 | $1K |
| 84484 | <1% | 108 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 25 | $999.14 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 544 | $863.41 |
| 87420 | <1% | 39 | $533.39 | |
| 81025 | <1% | 68 | $481.05 | |
| 71045 | Radiologic examination, chest; single view | <1% | 64 | $395.29 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 516 | $377.09 |
| 80306 | <1% | 27 | $367.25 | |
| 87186 | <1% | 39 | $301.11 | |
| 73110 | <1% | 13 | $259.95 | |
| 73610 | <1% | 13 | $221.76 | |
| 86703 | <1% | 13 | $143.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 135 | $127.92 |
| 82962 | <1% | 38 | $118.46 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 47 | $95.72 |
| J2704 | Injection, propofol, 10 mg | <1% | 66 | $72.73 |
| 86901 | <1% | 12 | $40.59 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 85 | $36.68 |
| 82570 | <1% | 14 | $27.68 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 290 | $20.43 |
| 80050 | General health panel | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFOWLER, KATHRYN (SENIOR VP, CFO)
Parent organizationST LUKES HEALTH SYSTEM LTD
| Provider | Location | Paid |
|---|---|---|
| ST Lukes Clinic-Treasure Valley LLC | Boise, ID | $59.26M |
| ST Luke's Clinic LLC | Twin Falls, ID | $39.50M |
| ST Lukes Regional Medical Center | Boise, ID | $24.98M |
| ST. Luke's Magic Valley Regional Medical Center, LTD. | Twin Falls, ID | $7.95M |
| ST Lukes Clinic-Treasure Valley LLC | Mountain Home, ID | $6.86M |
| Magic Valley Paramedics L L C | Twin Falls, ID | $4.57M |
| ST Lukes Clinic-Treasure Valley LLC | Baker City, OR | $2.08M |
| ST Lukes Nampa Medical Center LTD | Nampa, ID | $1.87M |
| ST Luke's Regional Medical Center | Meridian, ID | $1.55M |
| ST Lukes Regional Medical Center | Mountain Home, ID | $942K |
| ST Lukes Clinic - Wood River LLC | Ketchum, ID | $717K |
| ST Lukes Clinic - Mccall LLC | Mccall, ID | $576K |
| ST Luke's Regional Medical Center | Meridian, ID | $397K |
| ST. Luke's Magic Valley Regional Medical Center LTD | Twin Falls, ID | $300K |
| ST Lukes Wood River Medical Center LTD | Ketchum, ID | $174K |
| ST Lukes Mccall LTD | Mccall, ID | $149K |
| ST Lukes Regional Medical Center | Boise, ID | $49K |
| ST Lukes Magic Valley Regional Medical Center LTD | Twin Falls, ID | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.